Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now states that no participants are being sought, signaling closed recruitment. It also adds quick-access sections such as How to Read a Study Record, Common Questions, How to Join a Study, and updates the Intervention/Treatment heading along with a site revision note (v3.6.0).SummaryDifference0.4%

- Check16 days agoChange DetectedThe page's revision label was updated to v3.5.5, replacing the prior version v3.5.4, indicating a minor site update behind the scenes.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page was published. This update reflects version control activity rather than a change to the study content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s technical release/version label was updated from **v3.5.2** to **v3.5.3**, reflecting a platform update rather than any change to the study information.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.